# Antidepressants During Pregnancy Not Linked to Autism, ADHD
A major new study provides reassurance for pregnant people taking antidepressants. Researchers found no connection between prenatal antidepressant use and increased risk of autism or ADHD in children.
This finding addresses a concern that has worried many expectant parents and their doctors. Previous smaller studies raised questions about whether selective serotonin reuptake inhibitors (SSRIs) and other antidepressants might affect fetal brain development. The new research, which examined a large population of children born to mothers taking these medications, found no elevated risk.
The study matters because untreated depression during pregnancy carries its own documented risks. Maternal depression increases the chance of preterm birth, low birth weight, and developmental delays. It also raises the risk that mothers will experience postpartum depression, which affects bonding and early childhood development.
For pregnant people with depression, the decision to continue medication becomes clearer with this evidence. Stopping antidepressants abruptly can trigger relapse, leaving both parent and baby vulnerable. Researchers emphasize that the decision to take or discontinue antidepressants during pregnancy should involve careful discussion between the pregnant person, their obstetrician, and their psychiatrist or therapist.
The research validates what many reproductive psychiatrists have argued for years. The real danger lies not in taking prescribed antidepressants, but in the untreated mood disorder itself. Depression disrupts sleep, nutrition, and prenatal care adherence. It affects parental capacity postpartum and shapes the emotional environment babies experience from birth onward.
Mental health treatment during pregnancy isn't a luxury or optional add-on. It represents essential medical care. Pregnant people deserve access to their psychiatric medications without guilt or fear. This study provides evidence-based reassurance that choosing